about
The effect of lowering salt intake on ambulatory blood pressure to reduce cardiovascular risk in chronic kidney disease (LowSALT CKD study): protocol of a randomized trial.Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.[Management strategy for hypertension in chronic hemodialysis: a model applied to patient education (FTE)]Endogenous ouabain and the renin-angiotensin-aldosterone system: distinct effects on Na handling and blood pressure in human hypertension.Achieving salt restriction in chronic kidney disease.Potential benefits of renal diets on cardiovascular risk factors in chronic kidney disease patients.Endogenous digitalis: pathophysiologic roles and therapeutic applications.Role of endogenous cardiotonic steroids in sodium homeostasis.Fluid overload and inflammation--a vicious cycle.Sodium chloride promotes tissue inflammation via osmotic stimuli in subtotal-nephrectomized mice.Angiotensin II- and salt-induced kidney injury through Rac1-mediated mineralocorticoid receptor activation.Acute and chronic effects of dietary sodium restriction on renal tubulointerstitial fibrosis in cisplatin-treated rats.Therapeutic Education's Role in the Management of Hypertension in Chronic Hemodialysis PatientsModerately Decreased Dietary Salt Intake Suppresses the Progression of Renal Insufficiency in Rats with 5/6 NephrectomyDevelopment of a new clean methodology with ultrasound-assisted extraction for analysis of sodium in pet foods
P2860
Q34452637-2AF8C597-DDA6-49A4-9C2F-EFA647F719A4Q34605877-F8E16738-34AA-4FA3-AC9D-F52EAD12920CQ35104116-A6DE614B-962A-402D-9FA1-0B1C6F4884C7Q36464607-D36B4FC0-59E7-4818-A627-8FFA0CCC9C2DQ36520074-A87D2D27-6EE4-46FC-81D7-6CA935F1025AQ36892439-0FDBC717-2A56-49B7-BB9B-A5F5690AD686Q36952529-F682AD7D-506B-4A58-82F9-06CF7AAE82BAQ37192115-6C3C91F6-3ADD-44D1-8E30-6F1202B1435BQ38050198-46E91D71-741A-4E44-89F0-5BE71FCF529DQ38717770-534DA220-E518-42CA-9AE6-A3C5A81EAAA7Q41896485-74597D36-9A65-43C9-BFEA-A2FF342C9480Q43786434-8CF6C759-64F0-4794-8A7D-0B247C0C2AEAQ58997260-236DDD8D-57EC-4818-B448-20164F8E66DEQ59051018-C3FA87F0-3B0E-4E22-A767-4486E6E11E45Q59193562-7B199C9A-A81D-4A1E-B836-AB60789E50B5
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Salt--a potential 'uremic toxin'?
@ast
Salt--a potential 'uremic toxin'?
@en
type
label
Salt--a potential 'uremic toxin'?
@ast
Salt--a potential 'uremic toxin'?
@en
prefLabel
Salt--a potential 'uremic toxin'?
@ast
Salt--a potential 'uremic toxin'?
@en
P2093
P2860
P356
P1433
P1476
Salt--a potential 'uremic toxin'?
@en
P2093
Christian Morath
Eberhard Ritz
Ralf Dikow
Vedat Schwenger
P2860
P356
10.1159/000089439
P577
2006-01-01T00:00:00Z